Detection and quantification of mutations in the plasma of patients with colorectal tumors
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The early detection of cancers through analysis of circulating DNA could have a substantial impact on morbidity and mortality. To achieve this goal, it is essential to determine the number of mutant molecules present in the circulation of cancer patients and to develop methods that are sufficiently sensitive to detect these mutations. Using a modified version of a recently developed assay for this purpose, we found that patients with advanced colorectal cancers consistently contained mutant adenomatous polyposis coli ( APC ) DNA molecules in their plasma. The median number of APC DNA fragments in such patients was 47,800 per ml of plasma, of which 8% were mutant. Mutant APC molecules were also detected in >60% of patients with early, presumably curable colorectal cancers, at levels ranging from 0.01% to 1.7% of the total APC molecules. These results have implications for the mechanisms through which tumor DNA is released into the circulation and for diagnostic tests based on this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is a crucial consideration when considering cfDNA as a template as its concentration can range considerably; from 2 to 30 ng/ml plasma in healthy individuals to 180–600 ng/ml plasma both during pregnancy and in cancer patients (13,16,18,22–24).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationJahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1977) · PubMed · Cited by 1,801
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Self-citationDressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844
Self-citation
Research works printed but not linked: 4
- 10.1002/(SICI)1096-9896(200001)190:1<6::AID-PATH486>3.0.CO;2-M · doi:10.1002/(sici)1096-9896(200001)190:1<6::aid-path486>3.0.co;2-m
- Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. (1977) Cancer Res. 37, 646-650.837366
- Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M. A. & Tavecchio, L. (2001) Cancer Res. 61, 4675-4678.11406535
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D. & Knippers, R. (2001) Cancer Res. 61, 1659-1665.11245480
Cited by
Items 201–300 of 1,000
Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy
Fan, H. C., Blumenfeld, Y. J., El-Sayed, Y. Y., Chueh, J., & Quake, S. R. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.03.002 · Cited by 108
The feasibility of using mutation detection in ctDNA to assess tumor dynamics
Yi, X., Ma, J., Guan, Y., Chen, R., Yang, L. M., & Xia, X. (2017) · International Journal of Cancer · doi:10.1002/ijc.30620 · Cited by 110
Cree, I. A., Uttley, L., Woods, H. B., Kikuchi, H., Reiman, A., Harnan, S., Whiteman, B. L., Taylor‐Phillips, S., Messenger, M. P., Cox, A., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3693-7 · Cited by 116
Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
van der Vaart, M., & Pretorius, P. J. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.08.027 · Cited by 111
Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
Vymetalkova, V. P., Červená, K., Bartu, L., & Vodička, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113356 · Cited by 118
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
Dao, J., Conway, P., Subramani, B., Meyyappan, D., Russell, S., & Mahadevan, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713219 · Cited by 121
The context and potential of epigenetics in oncology
Lopez, J., Percharde, M., Coley, H. M., Webb, A., & Crook, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604930 · Cited by 107
Mouliere, F. C., & Thierry, A. R. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.688023 · Cited by 113
Ribeiro‐Samy, S., Oliveira, M. I., Pereira‐Veiga, T., Muinelo‐Romay, L., Carvalho, S., Gaspar, J., Freitas, P. P., López‐López, R., Costa, C., & Diéguez, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-44401-1 · Cited by 110
Wang, X., Zhou, S., Chu, C., Yang, M. J., Huo, D., & Hou, C. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00674 · Cited by 104
Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
Cidado, J. R., & Park, B. H. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9264-2 · Cited by 120
Circulating Biomarkers in Breast Cancer
Seale, K. N., & Tkaczuk, K. H. R. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.09.006 · Cited by 132
Hohaus, S., Santangelo, R., Giachelia, M., Vannata, B., Massini, G., Cuccaro, A., Martini, M., Cesarini, V., Cenci, T., D’Alò, F., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3327 · Cited by 107
Molecular Tests for Colorectal Cancer Screening
Bosch, L. J. W., Carvalho, B. G., Fijneman, R. J. A., Jiménez, C. R., Pinedo, H. M., van Engeland, M., & Meijer, G. A. (2011) · Clinical Colorectal Cancer · doi:10.3816/ccc.2011.n.002 · Cited by 109
Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review)
Νikolouzakis, Τ. Κ., Vassilopoulou, L., Fragkiadaki, P., Sapsakos, T. M., Papadakis, G., Spandidos, D. A., Tsatsakis, A. M., & Tsiaoussis, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6330 · Cited by 136
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
Trujillo, B., Wu, A., Wetterskog, D., & Attard, G. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01881-9 · Cited by 116
Brychta, N., Krahn, T., & von Ahsen, O. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.257469 · Cited by 108
García-Foncillas, J., Alba, E., Aranda, E., Díaz-Rubio, E., López-López, R., Tabernero, J., & Vivancos, A. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx501 · Cited by 101
Wielscher, M., Vierlinger, K., Kegler, U., Ziesche, R., Gsur, A., & Weinhäusel, A. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.025 · Cited by 112
Kidess, E., Heirich, K., Wiggin, M., Vysotskaia, V. S., Visser, B. C., Marziali, A., Wiedenmann, B., Norton, J. A., Lee, M., Jeffrey, S. S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3041 · Cited by 105
Circulating Tumor DNA: Measurement and Clinical Utility
Donaldson, J. M., & Park, B. H. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-041316-085721 · Cited by 108
Epigenetic biomarkers of promoter DNA methylation in the new era of cancer treatment
Yamashita, K., Hosoda, K., Nishizawa, N., Katoh, H., & Watanabe, M. (2018) · Cancer Science · doi:10.1111/cas.13812 · Cited by 118
Tan, R., Phua, S. K. A., Soong, Y. L., Oon, L. L. E., Chan, K. S., Lucky, S. S., Mong, J. C. Y., Tan, M. H., & Lim, C. M. (2020) · 癌症:英文版 · doi:10.1002/cac2.12100 · Cited by 99
Jiang, R., Lu, Y., Ho, H. H., Li, B., Chen, J., Lin, M., Li, F., Wu, K., Wu, H., Lichterman, J. N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6330 · Cited by 108
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
Lodewijk, I., Dueñas, M., Rubio, C., Munera-Maravilla, E., Segovia, C., Bernardini, A., Teijeira, A., Paramio, J. M., & Suárez-Cabrera, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092514 · Cited by 108
Sánchez, C., Roch, B., Mazard, T., Blache, P., Dache, Z. A. A., Pastor, B., Pisareva, E., Tanos, R., & Thierry, A. R. (2021) · JCI Insight · doi:10.1172/jci.insight.144561 · Cited by 111
Singh, N., Gupta, S., Pandey, R. M., Chauhan, S. S., & Saraya, A. (2015) · Cancer Investigation · doi:10.3109/07357907.2014.1001894 · Cited by 98
Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?
Yang, M., Forbes, M. E., Bitting, R. L., O’Neill, S. S., Chou, P. C., Topaloĝlu, Ü., Miller, L. D., Hawkins, G. A., Grant, S. C., DeYoung, B. R., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx766 · Cited by 109
Zou, H., Taylor, W. R., Harrington, J. J., Hussain, F. T. N., Cao, X., Loprinzi, C. L., Levine, T. R., Rex, D. K., Ahnen, D. J., Knigge, K. L., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.023 · Cited by 102
Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?
Fariñas, S. C., Lewintre, E. J., Herreros‐Pomares, A., & Camps, C. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.10.02 · Cited by 105
Jylhävä, J., Kotipelto, T., Raitala, A., Jylhä, M. K., Hervonen, A., & Hurme, M. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.11.001 · Cited by 97
Pécuchet, N., Zonta, E., Didelot, A., Combe, P., Thibault, C., Gibault, L., Lours, C., Rozenholc, Y., Taly, V., Laurent‐Puig, P., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002199 · Cited by 103
Okajima, W., Komatsu, S., Ichikawa, D., Miyamae, M., Ohashi, T., Imamura, T., Kiuchi, J., Nishibeppu, K., Arita, T., Konishi, H., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i31.5650 · Cited by 101
Preanalytical variables that affect the outcome of cell-free DNA measurements
Ungerer, V., Bronkhorst, A. J., & Holdenrieder, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1750558 · Cited by 109
Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia
Goggins, M. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.05.003 · Cited by 109
Sánchez, C., Snyder, M. W., Tanos, R., Shendure, J., & Thierry, A. R. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0069-0 · Cited by 108
EGFR mutations in lung cancer: from tissue testing to liquid biopsy
Fenizia, F., Luca, A. D., Pasquale, R., Sacco, A., Forgione, L., Lambiase, M., Iannaccone, A., Chicchinelli, N., Franco, R., Rossi, A., et al. (2015) · Future Oncology · doi:10.2217/fon.15.23 · Cited by 99
Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
Vendrell, J. A., Mau‐Them, F. T., Béganton, B., Godreuil, S., Coopman, P. J., & Solassol, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020264 · Cited by 110
Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers
Trinidad, C. V., Tetlow, A. L., Bantis, L. E., & Godwin, A. K. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0184 · Cited by 108
At the dawn: cell-free DNA fragmentomics and gene regulation
Liu, Y. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01635-z · Cited by 111
Liquid Biopsies for Cancer: Coming to a Patient near You
Krishnamurthy, N., Spencer, E. G., Torkamani, A., & Nicholson, L. J. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010003 · Cited by 101
Increased plasma DNA integrity index in head and neck cancer patients
Jiang, W., Zahurak, M., Goldenberg, D., Milman, Y., Park, H. L., Westra, W. H., Koch, W., Sidransky, D., & Califano, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22250 · Cited by 91
Rachiglio, A. M., Abate, R. E., Sacco, A., Pasquale, R., Fenizia, F., Lambiase, M., Morabito, A., Montanino, A., Rocco, G., Romano, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10704 · Cited by 97
Kidess, E., Liu, H. E., Triboulet, M. M., Che, J., Ramani, V. C., Visser, B. C., Poultsides, G. A., Longacre, T. A., Marziali, A., Vysotskaia, V. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13350 · Cited by 101
Recent advances in circulating nucleic acids in oncology
Otandault, A., Anker, P., Dache, Z. A. A., Guillaumon, V., Meddeb, R., Pastor, B., Pisareva, E., Sánchez, C., Tanos, R., Tousch, G., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz031 · Cited by 97
Mauri, G., Pizzutilo, E. G., Amatu, A., Bencardino, K., Palmeri, L., Bonazzina, E. F., Tosi, F., Carlo Stella, G., Burrafato, G., Scaglione, F., et al. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.12.006 · Cited by 90
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
Bruhm, D. C., Vulpescu, N. A., Foda, Z. H., Phallen, J. A., Scharpf, R. B., & Velculescu, V. E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00795-x · Cited by 118
Madic, J., Piperno-Neumann, S., Servois, V., Rampanou, A., Milder, M., Trouiller, B., Gentien, D., Saada, S., Assayag, F., Thuleau, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0309 · Cited by 91
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance
Siravegna, G., & Bardelli, A. (2014) · Genome biology · doi:10.1186/s13059-014-0449-4 · Cited by 94
Circulating-tumor DNA as an early detection and diagnostic tool
Butler, T. M., Spellman, P. T., & Gray, J. W. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.12.003 · Cited by 96
Sun, Y., Sun, Y., Tian, W., Liu, C., Gao, K., & Li, Z. (2017) · Chemical Science · doi:10.1039/c7sc04975g · Cited by 88
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
Arisi, M. F., Dotan, E., & Fernandez, S. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084441 · Cited by 103
Pécuchet, N., Rozenholc, Y., Zonta, E., Pietrasz, D., Didelot, A., Combe, P., Gibault, L., Bachet, J., Taly, V., Fabre, E., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.258236 · Cited by 94
Aldea, M. D., Hendriks, L. E. L., Mezquita, L., Jovelet, C., Planchard, D., Auclin, É., Remón, J., Howarth, K., Benítez, J. C., Gazzah, A., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.11.024 · Cited by 93
When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review
Rodríguez, J. K., Ávila, J., Rolfo, C. D., Ruíz-Patiño, A., Russo, A., Ricaurte, L., Ordóñez‐Reyes, C., Arrieta, O. G., Zatarain-Barrón, Z. L., Recondo, G., et al. (2021) · Oncology and Therapy · doi:10.1007/s40487-021-00144-6 · Cited by 98
Yamada, T., Iwai, T., Takahashi, G., Kan, H., Koizumi, M., Matsuda, A., Shinji, S., Yamagishi, A., Yokoyama, Y., Tatsuguchi, A., et al. (2016) · Cancer Science · doi:10.1111/cas.12959 · Cited by 85
Whale, A. S., Jones, G. M., Pavšič, J., Dreo, T., Redshaw, N. M., Akyürek, S., Akgöz, M., Divieto, C., Sassi, M. P., He, H., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.285478 · Cited by 95
Biomarkers of Angiogenesis in Colorectal Cancer: Supplementary Issue: Biomarkers for Colon Cancer
Mousa, L., Salem, M. E., & Mikhail, S. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s25250 · Cited by 89
Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing
Lau, B. T., Almeda, A. F., Schauer, M. C., McNamara, M., Bai, X., Meng, Q., Partha, M. A., Grimes, S. M., Lee, H., Heestand, G. M., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01178-3 · Cited by 92
Gene methylation and early detection of genitourinary cancer: the road ahead
Cairns, P. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2170 · Cited by 84
Epigenetics and epigenetic alterations in pancreatic cancer.
Omura, N., & Goggins, M. (2009) · PubMed Central · Cited by 105
Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
Wang, J., & Bettegowda, C. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.08.007 · Cited by 93
Role of circulating-tumor DNA analysis in non-small cell lung cancer
Jiang, T., Ren, S., & Zhou, C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.013 · Cited by 87
Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy
Hu, C., Jiang, W., Lv, M., Fan, S., Lu, Y., Wu, Q., & Pi, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.792046 · Cited by 89
Emerging technologies for salivaomics in cancer detection
Kaczor‐Urbanowicz, K. E., Carreras‐Presas, C. M., Kaczor, T., Tu, M. K., Fang, W., García-Godoy, F., & Wong, D. T. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13007 · Cited by 87
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
Petit, J. A., Carroll, G. M., Gould, T., Pockney, P. G., Dun, M. D., & Scott, R. J. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.11.029 · Cited by 88
Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
Crigna, A. T., Samec, M., Koklesová, L., Líšková, A., Giordano, F. A., Kubatka, P., & Golubnitschaja, O. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00226-x · Cited by 81
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147974 · Cited by 100
Watts, G. S., Futscher, B. W., Holtan, N., DeGeest, K., Domann, F. E., & Rose, S. L. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-47 · Cited by 81
Demuth, C., Spindler, K. G., Johansen, J. S., Pallisgaard, N., Nielsen, D. L., Høgdall, E. V. S., Vittrup, B., & Sørensen, B. S. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.07.013 · Cited by 83
Validation of a blood plasma separation system by biomarker detection
Kersaudy-Kerhoas, M., Kavanagh, D. M., Dhariwal, R. S., Campbell, C. J., & Desmulliez, M. P. Y. (2010) · Lab on a Chip · doi:10.1039/b926834k · Cited by 80
Promoter methylation and the detection of breast cancer
Brooks, J. D., Cairns, P., & Zeleniuch‐Jacquotte, A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9415-y · Cited by 90
Sonnenberg, A., Marciniak, J. Y., McCanna, J. P., Krishnan, R., Rassenti, L. Z., Kipps, T. J., & Heller, M. J. (2013) · Electrophoresis · doi:10.1002/elps.201200444 · Cited by 83
A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer
Pedersen, S. K., Baker, R. T., McEvoy, A., Murray, D. H., THOMAS, M. L., Molloy, P. L., Sue, M., Lockett, T. J., Young, G. P., & LaPointe, L. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125041 · Cited by 84
Namløs, H. M., Boye, K., Mishkin, S. J., Barøy, T., Lorenz, S., Bjerkehagen, B., Stratford, E. W., Munthe, E., Kudlow, B. A., Myklebost, O., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0174 · Cited by 85
Liquid biopsies and cancer omics
Amelio, I., Bertolo, R. G., Bove, P., Buonomo, O. C., Candi, E., Chiocchi, M., Cipriani, C., Daniele, N. D., Ganini, C., Juhl, H. H., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00373-0 · Cited by 87
Self-citationRole of Circulating Cell-Free DNA in Cancers
Raghu, A., Mani, S., Sridevi, V., Sundarsingh, S., & Rajkumar, T. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0167-y · Cited by 84
Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
Yang, Y., Wang, D., Jin, L., Yao, H., Zhang, J., Wang, J., Zhao, X., Shen, C., Chen, W., Wang, X., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20180322 · Cited by 92
Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma
Gall, T., Belete, S. C., Khanderia, E., Frampton, A. E., & Jiao, L. R. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.03.020 · Cited by 83
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?
Pittella-Silva, F., Chin, Y. M., Chan, T., Nagayama, S., Miyauchi, E., Low, S., & Nakamura, Y. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa103 · Cited by 86
Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment
Song, C., Liu, Y., Fontana, R. E., Makrigiorgos, A., Mamon, H. J., Kulke, M. H., & Makrigiorgos, G. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw650 · Cited by 76
Targeted Detection of Single-Nucleotide Variations: Progress and Promise
Abi, A., & Safavi, A. (2019) · ACS Sensors · doi:10.1021/acssensors.8b01604 · Cited by 78
Berger, B. M., & Ahlquist, D. A. (2011) · Pathology · doi:10.1097/pat.0b013e3283502fdf · Cited by 80
Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies
Ralla, B., Stephan, C., Meller, S., Dietrich, D., Kristiansen, G., & Jung, K. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.914888 · Cited by 80
Liu, X., Ren, J., Luo, N., Guo, H., Zheng, Y., Li, J., Tang, F., Wen, L., & Peng, J. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0689-y · Cited by 83
The evolving role of liquid biopsy in lung cancer
Malapelle, U., Pisapia, P., Pepe, F., Russo, G., Buono, M., Russo, A., Gomez, J. E., Khorshid, O., Mack, P. C., Rolfo, C. D., et al. (2022) · Lung Cancer · doi:10.1016/j.lungcan.2022.08.004 · Cited by 80
Gold Nanoparticle Based Platforms for Circulating Cancer Marker Detection
Huang, X., O’Connor, R., & Kwizera, E. A. (2017) · Nanotheranostics · doi:10.7150/ntno.18216 · Cited by 80
Cell-Free DNA: Applications in Different Diseases
Ranucci, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8973-7_1 · Cited by 84
Zhang, L., Liang, Y., Li, S., Zeng, F., Meng, Y., Chen, Z., Liu, S., Tao, Y., & Yu, F. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0989-z · Cited by 73
Choy, L. Y. L., Peng, W., Jiang, P., Cheng, S. H., Yu, S. C. Y., Shang, H., Tse, O. Y. O., Wong, J., Wong, V. W., Wong, G. L., et al. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac086 · Cited by 74
New Perspectives on the Importance of Cell-Free DNA Biology
Bronkhorst, A. J., Ungerer, V., Oberhofer, A., Gabriel, S., Polatoglou, E., Randeu, H., Uhlig, C., Pfister, H., Mayer, Z., & Holdenrieder, S. (2022) · Diagnostics · doi:10.3390/diagnostics12092147 · Cited by 83
Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology
García-Olmo, D. C., González-Masiá, & García‐Olmo, D. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s44668 · Cited by 85
Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer
Ganepola, G. A. P., Nizin, J. S., Rutledge, J. R., & Chang, D. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i4.83 · Cited by 78
Integrative analysis of multi-omics data for liquid biopsy
Chen, G., Zhang, J., Fu, Q., Taly, V., & Tan, F. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02048-2 · Cited by 91
Predicting the outcome of chemotherapy for lung cancer
Rosell, R., Cecere, F. L., Santarpía, M., Reguart, N., & Tarón, M. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.01.011 · Cited by 75
Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies
Abbou, S. D., Shulman, D. S., DuBois, S. G., & Crompton, B. D. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27595 · Cited by 72
Chang, G. A., Tadepalli, J. S., Shao, Y., Zhang, Y., Weiss, S. A., Robinson, E. M., Spittle, C., Furtado, M. R., Shelton, D. N., Karlin-Neumann, G. A., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.09.005 · Cited by 76
DNA methylation in circulating tumour DNA as a biomarker for cancer.
Ruth E Board, Knight, L., Greystoke, A., Blackhall, F. H., Hughes, A. M., Dive, C., & Ranson, M. (2008) · PubMed Central · Cited by 72
Elevated level of cell-free plasma DNA is associated with breast cancer
Zhong, X. Y., Ladewig, A., Schmid, S. M., Wight, E., Hahn, S., & Holzgreve, W. (2007) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-007-0345-1 · Cited by 82
Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer
Bellassai, N., & Spoto, G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9806-3 · Cited by 78
Metadata
- Authors
- Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-10-28
- Volume
- 102
- Issue
- 45
- Pages
- 16368-16373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1283450
- OpenAlex
- W2015438948
- Cited by
- 1,188
- References
- 39
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 44 · 2023: 75 · 2022: 91 · 2021: 76 · 2020: 88 · 2019: 111 · 2018: 97 · 2017: 93 · 2016: 90 · 2015: 66 · 2014: 61 · 2013: 46 · 2012: 44
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA62924, CA43460, CA57345)
- National Cancer Institute (CA 57345, CA43460, R37CA043460, R01CA057345, P50CA062924, R37CA057345, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- circulating tumor DNA, colorectal cancer, APC mutation, liquid biopsy, early cancer detection
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sensitivity and Specificity, Colorectal Neoplasms, Genes, APC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.